Results 21 to 30 of about 591,464 (366)

Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications

Psychotherapy and Psychosomatics, 2020
Studies on psychotropic medications decrease, discontinuation, or switch have uncovered withdrawal syndromes. The present overview aimed at analyzing the literature to illustrate withdrawal after decrease, discontinuation, or switch of psychotropic ...
F. Cosci, G. Chouinard
semanticscholar   +1 more source

Clopidogrel discontinuation after acute coronary syndromes: frequency, predictors and associations with death and myocardial infarction--a hospital registry-primary care linked cohort (MINAP-GPRD). [PDF]

, 2011
AIMS: Adherence to evidence-based treatments and its consequences after acute myocardial infarction (MI) are poorly defined. We examined the extent to which clopidogrel treatment initiated in hospital is continued in primary care; the factors predictive ...
Van Staa, Tjeerd; id_orcid, K. A. A. Fox, Hemingway, Harry, Boggon, Rachael, van Staa, TP, H. Hemingway, Boggon, R, Begg, Alan, Fox, KAA, Ray, KK, Emmas, C, Timmis, A, T. P. van Staa, A. Begg, Begg, A, R. Boggon, C. Emmas, Fox, Keith A A, Fox, Keith AA, Ray, Kausik K, K. K. Ray, Emmas, Cathy, van Staa, Tjeerd P, Timmis, Adam, Hemingway, H, A. Timmis   +25 more
core   +1 more source

Association Between Renin-Angiotensin System Blockade Discontinuation and All-Cause Mortality Among Persons With Low Estimated Glomerular Filtration Rate.

JAMA Internal Medicine, 2020
Importance It is uncertain whether and when angiotensin-converting enzyme inhibitor (ACE-I) and angiotensin II receptor blocker (ARB) treatment should be discontinued in individuals with low estimated glomerular filtration rate (eGFR).
Yao Qiao, Jung-Im Shin, Teresa K. Chen, Lesley A. Inker, J. Coresh, G. Alexander, J. Jackson, Alex R. Chang, Morgan E. Grams   +8 more
semanticscholar   +1 more source

Discontinuation of secondary prophylaxis against Pneumocystis carinii pneumonia in patients with HIV infection who have a response to antiretroviral therapy [PDF]

, 2001
Background: Patients with human immunodeficiency virus (HIV) infection and a history of Pneumocystis carinii pneumonia are at high risk for relapse if they are not given secondary prophylaxis. Whether secondary prophylaxis against P.
H. Furrer, Uberti-Foppa, C., Pradier, C., Bickel, M, Monforte, A D´Arminio, Bickel, M., M. M. E. Schneider, Uberti-Foppa, C, O. Kirk, Furrer, H, Kirk, O., Schneider, M. M., Kirk, O, Lundgren, Jens Dilling, Ledergerber, B., Mocroft, A., Ledergerber, B, Lundgren, J.D., M. Bickel, P. Reiss, Lundgren, J. D., d'Arminio Monforte, A., Pradier, C, A. d'Arminio Monforte, Lederberger, B., Furrer, H., Reiss, P, Schneider, MM, A. Mocroft, for eight European HIV Cohorts, B. Ledergerber, C. Pradier, J. D. Lundgren, Schneider, M.M.E., Mocroft, A, Reiss, P., C. Uberti Foppa   +36 more
core   +1 more source

Approaches for discontinuation versus continuation of long-term antidepressant use for depressive and anxiety disorders in adults.

Cochrane Database of Systematic Reviews, 2021
BACKGROUND Depression and anxiety are the most frequent indication for which antidepressants are prescribed. Long-term antidepressant use is driving much of the internationally observed rise in antidepressant consumption.
Ellen Van Leeuwen, M. V. van Driel, M. Horowitz, T. Kendrick, M. Donald, A. De Sutter, L. Robertson, T. Christiaens   +7 more
semanticscholar   +1 more source

"One teabag is better than four": Participants response to the discontinuation of 2% PRO2000/5 microbicide gel in KwaZulu-Natal, South Africa. [PDF]

, 2011
INTRODUCTION: The Microbicides Development Programme evaluated the safety and effectiveness of 0.5% and 2% PRO2000/5 microbicide gels in reducing the risk of vaginally acquired HIV.
Mhlongo Nkosinathi, Ndlovu, Hlengiwe, Hoogland Yael, Ndlovu Hlengiwe, Gafos, M, Mhlongo, N, Mzimela, Misiwe, Hoogland, Y, Misiwe Mzimela, Yael Hoogland, Gafos, Mitzy, Mutemwa Richard, Mzimela Misiwe, Nkosinathi Mhlongo, Ndlovu, H, Mutemwa, Richard, Mutemwa, R, Mhlongo, Nkosinathi, Hlengiwe Ndlovu, Mitzy Gafos, Richard Mutemwa, Gafos Mitzy, Hoogland, Yael, Mzimela, M   +23 more
core   +1 more source

Discontinuation versus continuation of renin-angiotensin-system inhibitors in COVID-19 (ACEI-COVID): a prospective, parallel group, randomised, controlled, open-label trial

The Lancet Respiratory Medicine, 2021
Background SARS-CoV-2 entry in human cells depends on angiotensin-converting enzyme 2, which can be upregulated by inhibitors of the renin–angiotensin system (RAS).
A. Bauer, M. Schreinlechner, N. Sappler, T. Dolejsi, H. Tilg, B. Aulinger, G. Weiss, R. Bellmann-Weiler, C. Adolf, Dominik J. Wolf, Markus Pirklbauer, I. Graziadei, Hannes Gänzer, C. von Bary, A. May, E. Wöll, W. von Scheidt, T. Rassaf, D. Duerschmied, C. Brenner, S. Kääb, B. Metzler, M. Joannidis, Hans-Ulrich Kain, Norbert Kaiser, R. Schwinger, B. Witzenbichler, H. Alber, F. Straube, N. Hartmann, S. Achenbach, M. von Bergwelt‐Baildon, Lukas von Stülpnagel, S. Schoenherr, L. Forer, Sabine Embacher-Aichhorn, U. Mansmann, K. Rizas, S. Massberg, Marcin Gabriele Monika Marcel Manuel Lisa Stefan Stephan Bantkowiak Baur Baylacher Beaucamp Berger Besch Br, Marcin Bantkowiak, Gabriele Baur, Monika Baylacher, Marcel Beaucamp, M. Berger, L. Besch, S. Brunner, S. Budweiser, H. Bugger, R. Coletti, U. Dorwarth, J. Egresits, Elodie Eiffener, C. Faul, A. Finkenstedt, Konstantinos Gatos, Nadine Gauchel, F. Gindele, W. Grander, Markus Gunschl, F. Hartig, M. Hecht, T. Heer, L. Heger, M. Hentrich, L. Horvath, D. Keta, S. Kiechl, R. Kirchmaier, A. Klein, M. Klemm, E. Kolesnik, A. König, H. Kossmann, J. Kropáček, L. Lanser, A. Lother, A. Löw, A. Mahabadi, S. Malleier, G. Mayer, C. Müller, D. Müller-Wieland, B. Nagel, H. Neuwirt, C. Olivier, T. Raunegger, M. Reindl, S. Reinstadler, L. Riesinger, M. Schäffner, John E. Schier, J. Schock, Piet Schönherr, M. Schulz, Thomas Schütz, Johannes Schwarz, J. Siebermair, M. Siry, Anna Spaur, W. Sturm, Kristin Tessadri, F. Theurl, M. Theurl, Liz Thommes, C. Tiller, M. Toifl, M. Totzeck, Hedda von zur Mühlen, N. Vonderlin, R. Wakili, C. Wendtner, F. Wenner, D. Wimmert-Roidl, A. Zabernigg   +114 more
semanticscholar   +1 more source

Reasons and Associated Factors of Early Discontinuation of Implanon: A Follow-up Study from Lahore, Pakistan [PDF]

Liaquat National Journal of Primary Care, 2022
Background: Family planning is needed at this time when the world population is rapidly increasing. Etonogestrel sub-dermal implant is a highly effective long-acting and reversible sub-dermal contraceptive implant. Despite its success and enhancement in
Nida Arif, Maryam Shahid, Iffat Hamid, Noor Nishan, Bushra Arif, Abdullah Arif   +5 more
doaj   +1 more source

Intrauterine contraceptive discontinuation reasons among female trial participants living with HIV in Cape Town, South Africa: A qualitative analysis

Frontiers in Global Women's Health, 2023
IntroductionWhile young women in South Africa may navigate both HIV infection and pregnancy risks, intrauterine contraceptive (IUC) use is low. Though IUCs have low failure rates, concerns exist about whether the IUC is an appropriate method choice for ...
Subarna Pradhan, Elizabeth E. Tolley, Nontokozo Langwenya, Heidi E. Jones, Donald R. Hoover, Gregory Petro, Landon Myer, Catherine S. Todd   +7 more
doaj   +1 more source

Impact of Asparaginase Discontinuation on Outcome in Childhood Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group.

Journal of Clinical Oncology, 2020
PURPOSE Asparaginase (ASNase) is an important component of acute lymphoblastic leukemia (ALL) treatment, but is often discontinued because of toxicity.
S. Gupta, Cindy Y. Wang, E. Raetz, R. Schore, W. Salzer, E. Larsen, K. Maloney, L. Mattano, W. Carroll, N. Winick, S. Hunger, M. Loh, M. Devidas   +12 more
semanticscholar   +1 more source